Daniel is a psychiatrist and academic undertaking an MD(res) in psychological medicine within the Centre for Affective Disorders at IoPPN, KCL. He joined the department in 2022 having previously worked as a psychiatry registrar in East London.

His current research focus explores optimizing outcome measurement for depression through the assessment of symptom scales in their ability to detect meaningful improvements longitudinally, including a novel visual analog scale developed at the group called M3VAS. Dr Silman is also the lead study psychiatrist at KCL for the Horizon 2020 funded PSY-PGx study evaluating pharmaco-genetic supported prescribing, as well as other studies including SNAPPER which assesses treatment of ADHD which is comorbid with major psychiatric illnesses (depression and psychosis). He holds an honorary contract with SLaM Affective Disorders Service. Dr Silman is also interested in psychotherapy and is training towards a PGDip in mindfulness-based Core Process Psychotherapy.

Dr Silman holds MRCPsych (Nov 2020) having completed core-psychiatry training in Oxford, and an MSc in infectious disease immunology (2015) from London School of Hygiene and Tropical Medicine. 

Research Interests

• Depression treatments
• Outcome measurement

Teaching 

Dr Silman contributes to module teaching on the MSc for Affective Disorders and the supervision of dissertation projects